receptors and possibly inhibition of central L-type Ca + 2 channels (Little, 1991; Weight et al., 1992) . Although alcohol is classified as a sedative drug, it can also have stimulant effects (Charness et al., 1989; Little, 1991; Samson and Harris, 1992) . The concentration-and time-dependence of its inhibitory and stimulatory properties in humans has not yet been fully elucidated, partly due to the complicated and variable pharmacokinetics of alcohol, but also to the lack of standarised tests for the cns-effects of ethanol.
Alcoholic beverages are used commonly and worldwide ( Jang and Harris, 2007) , and the cns-effects of acute alcohol administration have been frequently quantified, a wide range of methods are used in such studies to study the different effects of alcohol. The sensitivity of these tests to the effects of alcohol has often not been completely ascertained, and concentration-or dose-effect relationships have only rarely been systematically reported. An overview of the sensitivity and dose-responsiveness of different cns-tests to the effects of alcohol would be useful for future studies focusing on acute alcohol effects or drug-alcohol interaction studies, and would constitute a useful collection of tests to evaluate the acute effects of alcohol on the cns.
A biomarker is described as a characteristic that is measured and evaluated as an indicator of normal or pathologic biological processes or pharmacologic responses to a therapeutic intervention (Colburn, 2003) . A biomarker can be any response measure that shows a clear, consistent response to meaningful doses, across studies from a sufficient number of different research groups. A dose-response relationship and a plausible relationship between the biomarker and the pharmacology of alcohol provide indications that a biomarker reflects pharmacological activity. Previously, these criteria were used to evaluate the usefulness of cns-tests (or functional biomarkers) for the effects of antipsychotic drugs (de Visser et al., 2001) , benzodiazepines (de Visser et al., 2003) , selective serotonin reuptake inhibitors (ssri's) (Dumont et al., 2005) , 3,4-methyleendioxymethamfetamine (mdma) (Dumont and Verkes, 2006) and Δ9-tetrahydrocannabinol (thc) (Zuurman et al., 2008) in healthy subjects. In general, these systematic reviews showed that only a small number of tests actually display proper characteristics for a meaningful abstract background The central nervous system (cns) effects of acute alcohol administration have been frequently assessed. Such studies often use a wide range of methods to study each of these effects. Unfortunately, the sensitivity of these tests has not completely been ascertained. methods A literature search was performed to recognize the most useful tests (or biomarkers) for identifying the acute cns-effects of alcohol in healthy volunteers. All tests were grouped in clusters and functional domains. Afterwards, the effect of alcohol administration on these tests was scored as improvement, impairment or as no effect. Furthermore, dose-response relationships were established. results A total number of 218 studies, describing 342 different tests (or test variants) were evaluated. Alcohol affected a wide range of cns-domains. Divided attention, focused attention, visuo-motor control and scales of feeling high and of subjective drug effects were identified as the most sensitive functional biomarkers for the acute cns-effects of alcohol. conclusions The large number of cns-tests that are used to determine the effects of alcohol interferes with the identification of the most sensitive ones and of drug-response relationships. Our results may be helpful in selecting rational biomarkers for studies investigating the acute cns-effects of alcohol or for future alcohol-interaction studies. introduction Ethyl alcohol, or ethanol causes dose-dependent central nervous system (cns) depression, which culminates in a state of general unconsciousness at high plasma concentrations (Little, 1991) . Prior investigations indicate that the predominant mechanism of cns depression involves selective alcohol interactions with ion channels that include allosteric enhancement of inhibition mediated by gamma-aminobutyric acid a (gaba-a) receptors, antagonism of excitation by n-methyl-d-aspartic acid (nmda) glutamate chapter 2 -functional biomarkers for the acute cns-effects of alcohol -19 -com prehensive cns-effect profile. Subsequently, inappropriate terms (e.g. 'in vitro', 'withdrawal' or 'deaths') were excluded from the search by using the 'not' search option. To obtain a manageable data-set, the search was limited to 'adult: 19-44 years', 'English', 'publication date from 1980 to 2008' and 'humans' . The complete search query, which yielded 1263 publications, is provided in table 1.
All publications obtained using this strategy underwent a thorough selection process. Initially, all articles were manually screened by title. Articles with irrelevant titles, given the selected search terms were discarded. Remaining articles were carefully studied and those that did not comply with the main objectives of this review (e.g. studies describing chronic alcohol effects) were discarded. In addition, studies investigating alcohol effects under specific artificial circumstances or conditions (e.g. sleep restriction, hypoxemia or anxiety paradigms), and studies dealing with more drugs or substances than alcohol alone (i.e. interaction studies), were not selected for further analysis, even if part of the design complied with the requirements of this review. Also, studies investigating a specific group of subjects other than regular healthy adult volunteers (e.g. heavy drinkers, patients or certain professionals) were disregarded. Studies in which such populations were discussed have been excluded from our analysis, as in our opinion such populations exhibit different responses to similar doses of alcohol compared to 'healthy volunteers' and thus may negatively bias our results (e.g. pilots are supposed to have faster baseline reaction times in tests that measure reaction time speed and alcoholics probably show less effects in studies measuring subjective effects). Thereby, we only excluded tests that were also frequently reported in healthy volunteers (but with different results) rather than tests that were specifically used in these special populations. Furthermore, studies with fewer than twelve participating healthy volunteers were also disregarded. Finally, papers that only mentioned the dose of alcohol instead of the blood alcohol concentration (bac) or the equivalent breath alcohol concentration (brac) were excluded, since these studies are less suitable for accurate analysis of the relationships between alcohol levels and effects.
At the end of this process, 218 titles were found eligible for review, which were subsequently evaluated based on the items summarized in table 2. The effect biomarker, that these tests differ between the various drug classes, and that most of these biomarkers belong to a small number of functional cns-domains: attention, memory, visuomotor and motor performance, subjective effects and certain neurophysiological tests (eye movements, electroencephalography). In addition, some drug classes cause specific neuroendocrine responses.
In an attempt to structure and subsequently evaluate the wide diversity of functional biomarkers for the cns-effects of ethanol, an extensive literature search was performed. Because of an apparent lack of standardization between the studies (even for the same tests), a structured procedure described previously was adopted, which includes progressive condensation of the tests into clusters of related tests and into domains of cns-functions, prior to the analyses (de Visser et al., 2001; de Visser et al., 2003; Dumont et al., 2005; Dumont and Verkes, 2006) . The criteria mentioned for meaningful biomarkers were eventually applied to the results. All effects of alcohol other than on the cns (e.g. on the liver) were excluded, except neuro-endocrine responses. The primary objective of the current review is to present a systemic overview of the usefulness of the different cns-tests described in the literature, which allow a reliable assessment of the acute cns-effects of alcohol in healthy adult volunteers. Accurate tests to measure the acute effect of alcohol on the cns are vital when the effect of alcohol in combination with a cns-drug is being studied. The results of this review may also be useful to rationally select sensitive cns-test for drug/alcohol interaction studies, which are often required for registration of new cns drugs.
methods

Structured literature evaluation
'Ethanol' (mesh), 'effect' and 'cns' were used as pivotal keywords to construct a MedLine search. This search included a large number of studies that were irrelevant for the specific primary objective of this review. Therefore, a wide range of specific cns-functions was added to these keywords to ensure a chapter 2 -functional biomarkers for the acute cns-effects of alcohol -21 -quantifications of the statistical significance levels for each individual dose. In these cases, efforts were made to estimate the individual dose effects from graphs or tables provided in the article. If this was impossible, only the largest average effect was assumed to be significant (in case of overall statistical significance) and smaller effects were considered non-significant.
Grouping of individual test results
Because of an apparent lack of standardization between the studies even for the same tests, a structured procedure was adopted as described previously (de Visser et al., 2001; de Visser et al., 2003; Dumont et al., 2005; Dumont and Verkes, 2006) in order to obtain a meaningful overview. This approach allowed the preservation of individual study data in early stages, followed by a progressive condensation of results into logical test clusters and functional (cns) domains. For example, all tests that determine the ability to discriminate flash-or flicker frequencies were grouped as the test cluster flicker discrimination and were subsequently categorized under the corresponding cns-domain attention. A compendium of neuropsychological tests from Spreen et al. (Spreen and Stretton, 1998) was primarily consulted to group functional tests into clusters of related tests or test variants. Additionally, the compendium of Lezak et al. (Lezak et al., 2004) was frequently consulted. Occasionally, a specific test was not described in these compendia. In these cases, the author's classification was followed or if necessary the test was clarified using other literature sources and classified by consensus. Tests and clusters were grouped further into domains that represent higher aggregates of integration of subjective, neuropsychological, neuroendocrine and neurophysiological functions. The neuropsychological domain is generally subdivided into executive functions, memory, attention, motor functions, language and perception (Spreen and Stretton, 1998) . For each test (or cluster), the compendia were also used to determine which cns-function was principally assessed by the test. Some tests provided different parameters with information on more than one functional domain. The results of the effects of a single test on different domains were scored separately, and the secondary effects were marked. results were captured into a Microsoft Excel® database. During this process the effect of alcohol on every individual test was scored, tests were grouped and alcohol levels were categorized.
Individual test results
Based on previous reviews (de Visser et al., 2001; de Visser et al., 2003; Dumont et al., 2005; Dumont and Verkes, 2006) , it was anticipated that in most cases no consistent quantitative results could be obtained from individual tests, because of the large diversity of methods, parameters and treatments. Therefore, the ability of a test to detect a statistically significant difference from placebo or baseline was scored as '+' (improvement/increase), '=' (no significant effect) or '-' (impairment/decrease). Subjective assessments of effects that were signs of improved cns-function or that most users would consider pleasurable (e.g. increase of a high or drug effect scale) were scored as an improvement/increase; symptoms of cns-depression or less desirable, adverse effects (e.g. increase of sedation or reduction of alertness) as an impairment/decrease. For physiological responses like changes in hormone levels or eeg-power a functional interpretation was not always obvious, and these results were scored as increases (+), decreases (-) or as no change (=), according to the direction of the reported effects. The total amounts of (+), (-) and (=) were determined within each cluster and percentages were calculated. Afterwards, these percentages were visually inspected to detect whether alcohol mainly impaired, improved or had no effect on a certain cluster. Subsequently, the sensitivity of each domain to alcohol was evaluated by inspection of the number of clusters within a certain domain that was clearly affected by alcohol.
Some studies explicitly reported the use of several different tests in the methods section, without presentation of the results, for no apparent reason, such as a separate publication. To avoid bias due to underreporting of negative results, it was assumed that these tests had not shown any significant effects and were scored accordingly. In some studies with different drug doses, overall significances were reported for drug effects, without (post hoc) chapter 2 -functional biomarkers for the acute cns-effects of alcohol -23 -In this way, the most frequently used tests and alcohol dosages could be compared for dose-dependency. For individual tests, the number of studies or the variability of alcohol levels were too small to determine meaningful doseeffect relationships. To obtain an overview of dose-effects, alcohol levels were pooled into 'lower', 'medium' and 'higher' levels. The levels were determined after inspection of the reported alcohol levels, but before relationships with pharmacodynamic tests were examined. The 'medium' level was chosen to be a bac or brac of 0.5 g•l-1 -0.7 g•l-1, because this resulted in an even distribution of studies across alcohol levels. This mid-range also included the legal driving limits for most western countries, and it would be useful to show which functional biomarkers are able to detect alcohol effects at this legal level. The 'lower' and 'higher' levels were all bac/brac's outside the medium range. This approach allowed the identification of tests or clusters that showed a consistent response across studies and alcohol concentrations.
Several studies reported the effects of both ascending or descending alcohol levels. In these cases, we considered a certain test to be effective in detecting alcohol effects, when at least one of both limbs was significantly affected. In addition, it was the intention to evaluate the effect of increasing or decreasing alcohol levels on individual tests that showed a consistent doseresponse relationship and were measured frequently enough.
results
Study characteristics
General study characteristics are reported in table 3.
Subject characteristics
The mean number of participants was 31 (23 males and 8 females). The mean age of participants was not reported in 35% of the cases. The mean age for all remaining articles was 24.8 years (range: 19 -42 years).
The effects of alcohol on multifactorial assessments like the Profiles of Mood States (poms) (McNair et al., 1971) , the Addiction Research Center Inventory (arci) (Haertzen, 1965) or the Bond & Lader Visual Analogue Scales (vas) (Bond and lader, 1974) were frequently reported. Subscales of such inventories were grouped together if they fell in the same cluster. Sometimes, individual subjective scales (and variants) were reported that could be regarded as variants from a basic form (e.g. subscales that are also part of more comprehensive tools like the Bond & Lader vas). Such scales were clustered according to the original scale with which they corresponded (e.g. into scale alertness, scale mood or scale calmness in case of a Bond & Lader subscale). Within such clusters, all scales showing a significant effect were grouped, whereas all scales showing no effect were grouped separately. In this way, scales within the same cluster that showed mixed results were also scored equivocally.
Comprehensive scoring instruments like the arci, the poms or the Drug Effect Questionnaire (deq) (Mintzer and Griffiths, 1999) can be subdivided into different subjective clusters (e.g. scale craving or scale alertness), but these subscales were not always reported separately. In these cases, the results of the composite scores were presented as part of the overall scale drug effect cluster for the deq and arci and the scale mood cluster for the poms. A similar procedure was followed for driving tests. In some cases the effects on a driving task were reported as effects on separate cns-functions like divided attention, reaction time and motor function. These driving tasks were grouped accordingly. However, when an overall composite driving score was reported, driving tests were grouped under the cluster driving.
Categorization of alcohol levels
The chance that a test will detect a difference from placebo is expected to increase with the alcohol level (measured through bac and/or brac). To investigate this possibility, it was determined for each individual test whether the proportion of statistically significant effects increased with bac/brac. chapter 2 -functional biomarkers for the acute cns-effects of alcohol -25 -corresponding cns-domains. Overall calculated significant alcohol effects (i.e. impairment/decrease (-), no significant change (=) or improvement/ increase (+)) on each cluster are shown together with the publications in which these effects were described. Table 6 shows that alcohol mainly caused either no effect or functional impairments. Impairments were most pronounced in the clusters divided attention, digit symbol substitution test-like (dsst-like), motor control, postural stability, visuo-motor control, scale performance and in auditory/verbal memory: immediate recall. These clusters were reported frequently enough (>10 times) to allow some general interpretations. Saccadic eye movements were also impaired in 90% of all cases, but these were described only seven times.
Individual memory tests sometimes showed improvements in delayed recall or recognition (between 10 and 33%, table 6), but never on tests of immediate or short term memory. In each of these studies, alcohol had been administered prior to the presentation of learning material. This is in line with the literature, which suggest that memory for information learned before the consumption of alcohol can be retroactively facilitated (Parker et al., 1980; Parker et al., 1981) .
Overall increases in effects were mainly found on the domain subjective experience. The clusters scale high and drug effect showed distinct increases of their subjective scores. In contrast, several different clusters of the subjective experience domain did not change much (marked as (=) in table 6) following alcohol administration (e.g. scales aggression, alertness, calmness, mood, and fatigue). The clusters production and semantics (language domain) were also hardly affected by alcohol. Because the effects of alcohol on the functional domain (neuro)endocrine and on several different clusters like production, scale depression, sleep, visual perception and electro-encephalography alpha (eeg alpha) were reported in only a small number of studies (<10), solid conclusions cannot be drawn on the sensitivity of these functional biomarkers.
Alcohol characteristics
In the majority of the cases (98%), alcohol was orally administered. In only 2% of all studies an intravenous administration procedure was described. Doses were not reported in 18 articles (8%). The calculated mean dose that was administered during trials was 0.69 g•kg-1 (sd: 0.25 g•kg-1). brac was measured in 199 studies (91%), whereas bac was used as a parameter in only 13 studies (6%). Six studies (3%) reported both values jointly. bac and brac were pooled together to calculate the mean alcohol concentration, which was 0.65 g•l-1 (sd: 0.20 g•l-1).
cns tests
This review yielded 342 different tests to assess the acute cns-effects of alcohol. Table 4 shows a distribution of the test frequencies across the literature search, indicating that a sizeable majority of all the described tests was used only once (69.3%) or no more than five times (89.2%). Tests that were used more than 10 times in the overall data-set are summarized in table 5. This arbitrary cut-off was used to get an indication of the most frequently used tests. The results of such solitary tests cannot be used to draw general conclusions about acute alcohol effects. Only scale intoxication was used frequently enough (26 times) to allow an individual analysis of alcohol responsiveness, but in all other cases tests needed to be clustered to increase numbers sufficiently for a more general interpretation.
Clustered alcohol effects
Individual tests were grouped into predefined clusters in an attempt to facilitate the general interpretation of the results. Table 6 summarizes the progressive condensation of all individual tests into clusters with their chapter 2 -functional biomarkers for the acute cns-effects of alcohol -27 -perception was only occasionally reported across different research groups, a mild dose-related deterioration was observed at the highest dose level. discussion A large number of tests are used in the literature to measure the acute cns effects of alcohol, even for the same effect. As with similar reviews for other drug classes (de Visser et al., 2001; de Visser et al., 2003; Dumont et al., 2005; Dumont and Verkes, 2006; Zuurman et al., 2008) , there were even more tests than articles: 342 in 218 publications. Almost 70% of all reported tests were only used once, and close to 90% was used five times or less. This lack of standardisation limits the comprehension of the effects of drugs on the cns. For alcohol, this is complicated further by complex (saturable) pharmacokinetics (with large intersubject variability related to induction of clearance, sex and other genetic factors), tolerance and withdrawal effects, drug and food interactions and differences between patient populations (alcoholics, drug abusers, social anxiety disorder, etc.). Understanding these complexities, and their functional consequences for social and problematic drinking, would be facilitated by the use of a limited number of well-characterised biomarkers for different alcohol effects, reflecting a range of relevant functions. With this background, tests were grouped into test clusters and functional domains. Prior reviews indicate that this technique served as a helpful tool in evaluating functional biomarkers for other drug effects (de Visser et al., 2001; de Visser et al., 2003; Dumont et al., 2005; Dumont and Verkes, 2006; Zuurman et al., 2008) . Although this methodology inevitably led to the loss of certain information, it resulted in a structured and comprehensive overview of the cnseffects of alcohol.
As far as possible, we used neuropsychological compendia (Spreen and Stretton, 1998; Lezak et al., 2004) ill, some categorization we undertook might seem arbitrary. The short memory test for example, was captured under executive functions instead of memory (as one might expect from the test name). Although this seems confusing at first sight, it is completely in line
Dose-response relationships
The ability to show clear dose-response relationships is an important requirement for a meaningful drug-effect biomarker (de Visser et al., 2001; de Visser et al., 2003; Dumont et al., 2005; Dumont and Verkes, 2006) . The dose also determines the sensitivity of a test for a drug, and the chance to detect an effect. Therefore, tests and clusters were examined for potential relationships to ethanol dose. An arbitrary cut-off of ten reports per dose level for at least two levels was used to study the dose-response relationships for the most frequently reported clusters (table 7) . Divided attention, scale high and scale drug effect were among the most sensitive clusters to detect alcohol effects, since a majority of tests were affected at the lowest alcohol dose levels. Many test clusters showed an increased proportion of significant drug effects at higher dose levels (table 7) . The most convincing dose-response impairments were found for focused attention (7% of the tests within this cluster were impaired in the <0.5 g•l-1 level, increasing to 62% at 0.5 -0.7 g•l-1 and 74% with levels >0.7 g•l-1), divided attention, reaction time, inhibition, working memory and visuo-motor control. Clear dose-related effects were also found for the cluster scale drug effect.
We made efforts to evaluate the effect of increasing and decreasing alcohol levels on individual tests that showed a consistent dose-response relationship and were reported frequently enough. Unfortunately, only few of these studies did address this issue. We therefore restricted our review to the main objective of creating an overview of the most sensitive cns-tests to measure the acute effects of alcohol.
All 15 scales of the cluster subjective high that were tested at the 0.5 -0.7 g•l-1 level increased after alcohol administration. Although they were only tested 9 times under high dose circumstances throughout the studies, all observed subjective high scales were affected by alcohol at this level. The effects on other frequently reported clusters described in table 7 either increased hardly with dose (e.g. evoked potential and scale craving) or were not clearly dose-related (scale calmness, scale mood and scale alertness). While visual chapter 2 -functional biomarkers for the acute cns-effects of alcohol -29 -clusters in the subjective experience domain. Both scales increased dosedependently, and showed effects in over 90% of the cases in the highest dose category. Many different subjective scales (or scale variants) are currently used in literature to measure subjective alcohol experience, but this review shows that only a few of those scales (subjective high and drug effects) are actually able to accurately measure the subjective effects of alcohol. Scales of calmness, mood and alertness seem to be less sensitive to alcohol.
The sensitivity of many clusters could not be assessed, because they were not reported frequently enough to allow an accurate evaluation (e.g. critical flicker fusion, visual perception and all the (neuro)endocrine clusters), although some of these uncommon clusters showed promising results (e.g. saccadic eye movements, eeg alpha and eeg theta). Clusters like semantics and scale aggression do not seem to be valuable biomarkers for alcohol effects, because the majority of the tests show no effect after alcohol administration in healthy volunteers. Some clusters showed significant overall alcohol effect in only a modest proportion of studies, like inhibition (50%) and working memory (53%). These executive tasks were measured frequently enough to allow a subdivision according to dose levels, which revealed larger percentages in the highest dose category of >0.7 g•l-1 (64 and 75% respectively). This indicates that alcohol effects (particularly at higher doses) can be masked for clusters that do not contain enough tests across the different doses to allow dose categorization. An important issue concerning tests within clusters like immediate recall (auditory/verbal memory), working memory and visuo-motor control is that all these functions may be affected by attention and concentration (Spreen and Stretton, 1998) . Attention tasks show an effect in 73-79% of cases at higher alcohol doses. Divided attention was even more sensitive, yielding significant results at low doses in over half the cases. The strong influence of alcohol on attention should be taken into account when looking at the results of other test clusters and functional domains that rely on attention.
Despite its infrequent appearance throughout our search, all tests assessing overall driving performance (i.e. cluster driving) were impaired under alcohol. Driving performance is an executive task that to a large extent relies on (visuo-)motor control and focused/divided attention. The most with the neuropsychological compendia we used. These authors state that the short memory test should be considered as a working memory (or executive) task rather than a pure memory task, because it is governed by brain areas that are also related to planning, organizing and time orientation. Longer-term memory tests in a stricter sense require much more hippocampal activity.
Tests within the most sensitive clusters as shown in table 6, which also show a clear dose-response relationship as shown in table 7 are considered most valuable. Thus, divided attention tests (i.e. attention domain), visuomotor control tests (i.e. motor domain) and subjective drug effect tests (i.e. domain subjective effects) are the most sensitive functional biomarkers for the acute effects of alcohol on the cns in healthy volunteers (at least according to the results of our review). Most clusters of the attention domain were clearly affected by alcohol. The cluster divided attention showed a higher sensitivity to alcohol compared to clusters like reaction time and focused attention, since these tests could detect lower alcohol levels. Tests within the divided attention cluster are more complex than those measuring simple reaction time or focused attention, and it is likely that lower doses of alcohol will have a larger impact on a more complex task than on a simpler version. Tests within the cluster reaction time can still be useful biomarkers, since 73% showed impairments at higher alcohol levels (>0.7 g•l-1), but they are less suitable to measure the impact of lower exposure. Similarly, executive clusters like working memory and inhibition are also quite capable of detecting alcohol effects at high doses (on average in 75% and 64% of the cases respectively).
Alcohol clearly impaired the three clusters of the motor domain, but only visuo-motor control tests were reported frequently enough at the different dose levels to allow a dose-response analysis. Although the effects on motor control and postural stability look promising, these tests can only be considered validated cns-biomarkers for alcohol effects if dose-response relationships are established. Alcohol effects on visuo-motor control were identified at concentrations >0.5 g•l-1 and a dose-dependent impairment was observed. The cluster visuo-motor control fulfilled the criteria as a useful functional biomarker. Scales of subjective high and drug effects were by far the most sensitive chapter 2 -functional biomarkers for the acute cns-effects of alcohol -31 -sensitive functional biomarkers to detect alcohol effects at the average legal driving level (i.e. the medium dose level) include tests of visuo-motor control as well as scales of subjective high and drug effect, followed by focused and divided attention. For visuo-motor control, the pursuit rotor task (a tracking task) was the most appropriate method to detect alcohol effects around the driving limit, at least in a laboratory setting. It is not surprising therefore, that all of the ten driving tests included in our review showed an effect of alcohol, including the two cases that studied the effects of a low dose. Reaction time is another aspect of driving, but individual reaction time tests only showed an impairment at medium levels in only half of the cases. This function seems less suitable to demonstrate the impact of alcohol on driving proficiency in a medico-legal setting.
In summary, the most sensitive functional biomarkers for the acute cnseffects of alcohol that were identified in this review are divided attention, focused attention, visuo-motor control, scale high and scale drug effect. Furthermore, reaction time, working memory and inhibition are also considered useful, but only at higher alcohol doses. Driving tasks also seemed to be sensitive to even low levels of alcohol, but this complicated setup was not used very frequently in the literature. The impairing effects of alcohol on the clusters dsst-like, motor control, postural stability and immediate recall (auditory/verbal memory) are noteworthy, but clear dose-effect relationships could not be established.
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chapter 2 -functional biomarkers for the acute cns-effects of alcohol -39 - (Quintyn et al., 1999) , , (Skalka et al., 1986) , , (Teo and Ferguson, 1986) , (Zuzewicz, 1981) , (Franken et al., 2007) (Chiang and Young, 2007) , (Harder and Reker, 1995) , (Jones and Neri, 1994) , (Jones, 1993) , (Ledin and Odkvist, 1991) , (Martinez and Martinez, 2003) et al., 2006) , (Blekher et al., 2002) , , , , (Watten and Lie, 1997) , (Wegner and Fahle, 1999b) , (Quintyn et al., 1999) , (Skalka et al., 1986) , , (Watten and Lie, 1996) , (Wegner and Fahle, 1999a) , (Hafstrom et al., 2007) et al., 1989) , , (Knowles and Duka, 2004) , , , , , (PierucciLagha et al., 2006) , , , , (Vogel-Sprott and Barrett, 1984) , (Breitmeier et al., 2007) Galbraith, 1986) , (Jones and Neri, 1994) , (Jones, 1993) , (Ledin and Odkvist, 1991) , , , (Martin et al., 1981) , (Martinez and Martinez, 2003) , (Mills and Bisgrove, 1983a) , , , , , (Asicioglu and Turan, 2003) , , (Beirness and VogelSprott, 1982) , , (Connors and Maisto, 1980) , (Degia et al., 2005) , , , (Fillmore and Vogel-Sprott, 1998) , (Fillmore and Vogel-Sprott, 1996a) , (Fillmore and Vogel-Sprott, 1996b) , (Fillmore and VogelSprott, 1995) , (Fogarty and Vogel-Sprott, 2002) , (Galbraith, 1986) , (George et al., 1990) , (Grant et al., 2000) , (Harrison and Fillmore, 2005a) , (Haubenreisser and Vogel-Sprott, 1983) , (Jones and Neri, 1994) , (Jones, 1993) , (Kearney and Guppy, 1988) , (Landauer and Howat, 1983) , , , , (Millar et al., 1999) , , , , (Thomson and Newlin, 1988) , , , , , , (Vogel-Sprott and Barrett, 1984) , , (Young and Pihl, 1982) , (Zack and Vogel-Sprott, 1993) , ) (n=40)
Neurophysiologic
Cluster Test (-) (=) (+) References (frequency)
eeg Alpha Electro-encephalography (eeg), Magnetoencephalography (meg) 6 38 56 (Cohen et al., 1993) , (Ehlers et al., 1999) , (Ehlers et al., 1989) , , , (Nikulin et al., 2005) , (n=7) eeg Beta Electro-encephalography (eeg), Magnetoencephalography (meg) 9 64 27 (Cohen et al., 1993) , (Ehlers et al., 1999) , (Nikulin et al., 2005) , 
eeg Delta Electroencephalography (eeg) 0 100 0 (Stenberg et al., 1994) (n=1) eeg Theta Electro-encephalography (eeg), Magnetoencephalography (meg) 0 22 78 (Ehlers et al., 1999) , (Ehlers et al., 1989) , , (Nikulin et al., 2005) , (Stenberg et al., 1994) , (Bartholow et al., 2003b) , (Chiang and Young, 2007) , , (Easdon et al., 2005) , (Erwin and Linnoila, 1981) , (Feely and Wood, 1982) , (Krause et al., 2002) , (Marinkovic et al., chapter 2 -functional biomarkers for the acute cns-effects of alcohol -41 -Scale Dizziness
Visual Analogue Scale (vas) (Scale Dizziness), Visual Analogue Scale (vas) (Scale Lightheadedness) 100 0 0 (Knowles and Duka, 2004) , , (Inder et al., 1995) , , , (Sarkola et al., 1999) (n=5) Other Neuroendocrine Substances AVP, Beta-Endorphin, Cholecystokinin, Dopamine, Melatonin, Prolactine, Serotonin 14 71 14 (Boyer et al., 2004) , (Inder et al., 1995) , (Sarkola et al., 1999) , (Rupp et al., 2007a) , , , (Harrison and Fillmore, 2005b) , (Harrison and Fillmore, 2005a) , (Landauer and Howat, 1983) , , (Millar et al., 1999) , (Mills and Bisgrove, 1983a) , (Mills and Bisgrove, 1983b) , , , , (Young and Pihl, 1982) 
Scale Symptoms
Alcohol Sensation Scale (Scale Anesthesia), Alcohol Sensation Scale (Scale Central/Warm/ Dynamic/Periphery/Nausea), Alcohol Sensation Scale (Scale Sensations), Alcohol Sensation Scale (Scale Somatic Sensations), Drug Effects Questionnaire (deq) (Scale Nausea), Sensation Scale (Scale Physical Sensations), Sensation Scale (Scale Symptoms), Von Zerssen's List of Complaints (Scale Complaints) 42 58 0 , , , , (Sher, 1985) , (Breitmeier et al., 2007) (n=6) chapter 2 -functional biomarkers for the acute cns-effects of alcohol 
